Shareholders Equity: The sum of preferred and common equity items.
EUROFINS SCIENT (ERFSF) had Shareholders Equity of $5.30B for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$2.97B |
|
$2.77B |
|
$9.04B |
|
$12.02B |
|
$2.37B |
|
$4.06B |
|
$4.35B |
|
$6.71B |
|
$5.30B |
|
$-721.19M |
|
|
Shareholders Equity |
$5.30B |
182.16M |
|
| Cash Flow Statement Financials | |
$597.46M |
|
$-463.73M |
|
$64.25M |
|
$696.10M |
|
$852.65M |
|
$156.54M |
|
$70.04M |
|
$-123.85M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|